Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

September 21, 2023
BioUtah News
BioUtah, Life Sciences Innovators Take Stage at Legislature’s Interim Meeting

The Utah Life Sciences Innovation Caucus hosted a lunch for all legislators during the September 18.

September 21, 2023
BioUtah News
NUSANO APPOINTS INDUSTRY EXPERT ALEXANDRE GIBIM AS CHIEF OPERATIONS OFFICER

EXECUTIVE WITH THREE DECADES OF SUCCESSFUL MULTINATIONAL OPERATIONS AND COMMERCIAL EXPERIENCE TO LEAD LAUNCH OF PROPRIETARY RADIOISOTOPE PRODUCTION PLATFORM

September 14, 2023
BioUtah News
BioUtah Participates in American Cancer Society Policy Panel Presentation

Kelvyn Cullimore, BioUtah’s CEO, participated as a panelist.

September 7, 2023
BioUtah News
Merit Medical Launches the Aspira® Evacuated Drainage Bottle

Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients

September 7, 2023
BioUtah News
Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

REC-3964 has been well tolerated in healthy volunteers with no reported serious adverse events. Recursion to explore initiating a Phase 2 proof-of-concept study in patients with recurrent Clostridioides difficile infection in 2024.

September 7, 2023
BioUtah News
New Myriad Genetics Survey Reveals Widespread Confusion and Misconceptions About Ovarian Cancer Screening Among a Majority of Women

Nearly three out of four women falsely believe a pap smear will reveal ovarian cancer presence

September 7, 2023
BioUtah News
Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work

Myriad Genetics announced Great Place To Work® and Fortune magazine have named Myriad Genetics to the 2023 Fortune Best Workplaces in Health Care™ List.

September 7, 2023
BioUtah News
Ultradent Named a Fortune Magazine Top Workplace for Third Straight Year

Ultradent Products is being recognized for the third consecutive year as a Fortune Magazine Top Large Workplace in Manufacturing and Production.

August 31, 2023
BioUtah News
Academia in Action: Searching for rare disease treatments

By their very nature, rare diseases impact a smaller portion of the population compared to conditions like cancer or the flu. While these diseases are less common, those affected by them, along with University of Utah researchers, are actively searching for a cure. Treating patients as individuals: Clement Chow Read more about Clement Chow’s research […]

August 31, 2023
BioUtah News
CLENE REPORTS SIGNIFICANTLY IMPROVED SURVIVAL BENEFIT OF 19.3 MONTHS AND SIGNIFICANTLY DELAYED CLINICAL WORSENING IN RESCUE-ALS OPEN-LABEL EXTENSION TWO YEAR FOLLOW-UP

19.3 month significant survival difference for CNM-Au8® treated participants versus placebo 52% significant decreased risk of ALS clinical worsening events Over 475 years of CNM-Au8 treatment exposure without any identified safety signals SALT LAKE CITY, Aug. 29, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) through its wholly owned subsidiary Clene Nanomedicine Inc., today announced […]

August 31, 2023
BioUtah News
BioTuesdays Features Halia Therapeutics CEO

In a recent interview with BioTuesdays, Halia and Co-Founder David Bearss, P.HD., said that the company is “growing to become a leader in targeting the NLRP3 inflammasome through a unique mechanism of action.” Closely-held Halia Therapeutics is developing a broad pipeline of novel therapies that are essential mediators of immune cell signaling with the potential […]

August 24, 2023
BioUtah News
Final Demolition Efforts Underway at The Point

Crews to topple final guard tower and showcase sustainable demolition practices   WHAT: Members of the media are invited to get a close-up look at demolition efforts currently underway at The Point. Attendees will get exclusive views of the preserved prison chapel called the “Chapel by the Wayside” and the state-of-the-art crushing facility used to […]

August 24, 2023
BioUtah News
Halia Therapeutics Celebrates Grand Opening of Its Lehi, Utah Headquarters

It was standing room only Tuesday as Halia Therapeutics held a ribbon cutting for the opening of its new headquarters in Lehi, Utah – a 20,000 square foot state-of-art drug research and development facility. CEO and co-founder, David Bearss, Ph.D. welcomed guests and shared the Halia mission: to develop novel therapies to improve the lives […]

August 24, 2023
BioUtah News
Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk

New collaboration increases access to genetic testing and can help identify patients with a high-risk for breast cancer SALT LAKE CITY, Aug. 22, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Onsite Women’s Health, a leading national provider of breast health services, today announced the […]

August 17, 2023
BioUtah News
BlueWind Medical’s Revi™ System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence

Revi redefines the treatment of Urgency Incontinence with a patient-centric implantable tibial neuromodulation solution that empowers patients

August 17, 2023
BioUtah News
Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH

A Leap Forward for Patients, a Promising Opportunity for Investors, and a Revolutionary Tool for Physicians

August 17, 2023
BioUtah News
August 17, 2023
BioUtah News
Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®

Prolaris is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1

August 10, 2023
BioUtah News
Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds

Recursion has predicted the protein target(s) for approximately 36 billion chemical compounds in the Enamine REAL Space, reported to be the world’s largest searchable chemical library. These advances were made possible by NVIDIA DGX Cloud supercomputing and the recent acquisition of Cyclica’s MatchMaker technology.

August 10, 2023
BioUtah News
Utah Company Developing Origami-inspired Technology Awarded NSF Grant to Advance Robotic Surgery

August 7, 2023 Four years ago, Jacob Sheffield was building world-class carbon fiber travel guitars for adventurers journeying to places as remote as Everest and Antarctica. Ian Esplin was growing viruses in bioreactors and developing therapies to combat antibiotic-resistant pathogens. The two came together and co-founded Bloom Surgical with a goal to empower robotic surgeons […]

August 10, 2023
BioUtah News
August 10, 2023
BioUtah News
Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment

ComboMATCH study uses genetic testing to match advanced cancer patients with targeted treatments

August 3, 2023
BioUtah News
Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd

World leading, multi-disciplinary experts advise on adoption of FDA authorized KidneyintelX.dkd across 14 million US patients with diabetes and chronic kidney disease

August 3, 2023
BioUtah News
Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment

SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced the completion of enrollment in its WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal study. Merit’s WAVE study is a prospective, randomized, controlled, multicenter study comparing the Merit WRAPSODY Cell-Impermeable Endoprosthesis […]